Tacrolimus versus narrowband ultraviolet b in the treatment of vitiligo: a clinical and laboratory evaluation.
Background Etiopathogenesis of vitiligo is unclear. Immunological background has a role.Interleukin 17 (IL-17) may play a role in its pathogenesis. There is no standard treatment regimen for vitiligo; however, calcineurin inhibitors may be an effective treatment option. Objective The aim was to evaluate tacrolimus versus narrowband ultraviolet B (NB-UVB) intreatment of vitiligo, both clinically and by measurement of IL-17 before ... إقراء المزيد